anti-CD3/undisclosed target T-cell engager Humabody (Crescendo Biologics)

N/A

Report date: 2026/03/19 16:58:16

Base Information

Drug Nameanti-CD3/undisclosed target T-cell engager Humabody (Crescendo Biologics)
Drug Alias Namemultivalent multiple target VH antibody fragment therapeutics (Crescendo Biologics)Humabody multi-specific T-cell engagers (Crescendo Biologics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulators
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCrescendo Biologics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrescendo Biologics Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A